EU’s Pharma Package falls short of Europe’s goal of global competitiveness
Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some experts.

Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some experts.
Lisata will utilise GATC's Multiomics Advanced Technology platform.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharma’s AI prospects get nudged into the future with EU’s AI act
Next-generation targeting for evolving HCP engagement
Are regulators keeping pace with AI adoption in clinical trials?